It is given as a subcutaneous injection (under the skin) once weekly. Learn more about where the best place to inject Zepbound is and what a typical dosing schedule looks like for the drug.

The US Food and Drug Administration (FDA) has approved the biologics license application for a subcutaneous formulation of ...

Subcutaneous immunotherapy injections for upper GI cancer come with certain risks and benefits. Learn more.

Subcutaneous injections are given just below the skin. A caregiver can also give you the injection. Your health care provider will give you instructions and teach you how to give yourself the ...

The FDA has approved a supplemental biologics application for Leqembi Iqlik subcutaneous injection for maintenance dosing in ...

After 18 months of intravenous administration of lecanemab (Leqembi), patients may now transition to subcutaneous delivery using the Leqembi Iqlik autoinjector.

Subcutaneous: Subcutaneous injections are given at a 45-degree angle, usually in the thigh (for babies under the age of 12 months) or upper-outer triceps area for people over 12 months.

While the approval of Leqembi Iqlik bodes well for Biogen and Eisai’s planned application for a subcutaneous induction ...

FDA approves the first subcutaneous version of nivolumab, making PD-1 inhibitors available to new groups of patients.

In an interview with CURE®, Dr. Eric K. Singhi shared his insights into the primary advantages of utilizing the subcutaneous formulation of Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) compared ...

The FDA has approved nivolumab and hyaluronidase-nvhy for subcutaneous injection in adults with solid tumors in which nivolumab is indicated, according to a press release.Nivolumab and ...